Heterozygous Familial Hypercholesterolemia (HeFH) trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Heterozygous Familial Hypercholesterolemia (HeFH) trials nationally

1

Recruiting in Ohio

1

Cities with sites

Cities in Ohio

Cincinnati 1

Recruiting trials in Ohio

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.